28/07/2000
Scientific Meeting on Vaccine-Derived Polioviruses (VDPVs)
VDPVs and their Implications – State of the Art
30 May – 1 June 2012, Geneva, Switzerland
The World Health Organization (WHO), in collaboration with the US Centers for Disease Control and Prevention (CDC) and Ministry of Health Japan, is organising a scientific meeting on vaccine-derived polioviruses (VDPVs) – ‘VDPVs and their Implications: State of the Art’ – on 30 May to 1 June 2012 at the International Conference Centre in Geneva, Switzerland.
The meeting will review the available scientific information on VDPVs; discuss the scientific, policy and programmatic implications of continued VDPV emergence and transmission; and, help inform the ‘roadmap for VDPV elimination’ for the post-oral polio vaccine (OPV) era.
Key discussion topics are anticipated to be:
- current state of knowledge on VDPVs, and adequacy of current surveillance strategies;
- knowledge gaps in epidemiology and virological aspects of circulating VDPVs, long-term carriers and other VDPVs;
- summary of the scientific research questions (virological and epidemiological) which can be addressed;
- contribution of modeling and risk analysis of population immunity in filling gaps in knowledge and understanding;
- improvements needed in programmatic response (laboratory procedures, outbreak response guidelines and supplemental immunization strategy) to more efficiently detect, control and prevent circulating VDPVs;
- future role of environmental surveillance and new diagnostics; and,
- role of potential findings and current and ongoing research to guide future immunization and risk management policy options (including use of tools such as vaccine stockpiles, inactivated polio vaccine, monovalent and bivalent oral polio vaccines and antivirals).
Related News
21/09/2023
A success story for public health despite extreme challenges of war
13/09/2023
13 September 2023
04/09/2023
Newly-appointed Pakistan leaders committed to delivering polio-free country
07/08/2023
Since the Republic of Congo first confirmed a case of cVDPV1 in March 2023 (the first such detection in more than two decades), the country has been pioneering the deployment of Geospatial Tracking Systems (GTS) to help curb further transmission.
25/07/2023
At the earliest signs of the ongoing conflict in Sudan, in the middle of April, WHO’s country team sprang into action. After all, conflict and infectious diseases are known to be comrades.
21/07/2023
Says commitment to polio eradication remains commendable, interruption of wild poliovirus is possible in six months with support from communities, government, administrative and security leadership
